CN Patent

CN109715612B — 促生长素抑制素调节剂及其用途

Assigned to Crinetics Pharmaceuticals Inc · Expires 2022-09-16 · 4y expired

What this patent protects

本文描述了作为促生长素抑制素调节剂的化合物，制备此类化合物的方法，包含此类化合物的药物组合物和药物，以及使用此类化合物治疗将会受益于促生长素抑制素活性调节的病况、疾病或病症的方法。

USPTO Abstract

本文描述了作为促生长素抑制素调节剂的化合物，制备此类化合物的方法，包含此类化合物的药物组合物和药物，以及使用此类化合物治疗将会受益于促生长素抑制素活性调节的病况、疾病或病症的方法。

Drugs covered by this patent

paltusotine-hydrochloride (PALTUSOTINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN109715612B
Jurisdiction: CN
Classification: —
Expires: 2022-09-16
Drug substance claim: No
Drug product claim: No
Assignee: Crinetics Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.